Dacomitinib (PF-00299804)

Suppliers

Names

[ CAS No. ]:
1110813-31-4

[ Name ]:
Dacomitinib (PF-00299804)

[Synonym ]:
Dacomitinib [USAN]
Dacomitinib (USAN/INN)
(2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-2-butenamide
(2e)-N-{4-[(3-Chloro-4-Fluorophenyl)amino]-7-Methoxyquinazolin-6-Yl}-4-(Piperidin-1-Yl)but-2-Enamide
(2E)-N-{4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl}-4-(1-piperidinyl)-2-butenamide
Dacomitinib
2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperidinyl)-, (2E)-
PF299804
PF-299804

Chemical & Physical Properties

[ Density]:
1.3±0.1 g/cm3

[ Boiling Point ]:
665.7±55.0 °C at 760 mmHg

[ Molecular Formula ]:
C24H25ClFN5O2

[ Molecular Weight ]:
469.939

[ Flash Point ]:
356.4±31.5 °C

[ Exact Mass ]:
469.168091

[ PSA ]:
82.87000

[ LogP ]:
5.12

[ Vapour Pressure ]:
0.0±2.0 mmHg at 25°C

[ Index of Refraction ]:
1.663

Safety Information

[ Hazard Codes ]:
Xi

[ HS Code ]:
29335990

Related Compounds

  • PF-00299804
  • N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine(DacomitinibImpurity)
  • (R)-PF-06256142
  • INCB8761(PF-4136309)
  • Gedatolisib (PF-05212384, PKI-587)
  • human pf-4
  • (3R)-3-hydroxy-3-(2-hydroxy-5-nitrophenyl)propanoic acid
  • 4-(aminomethyl)-4-(1H-pyrrol-2-yl)cyclohexan-1-ol
  • 2-Amino-3-(2,4-difluorophenyl)-2-methylpropan-1-ol
  • 2-[5-Methyl-2-(p-tolylamino)phenyl]-2-propanol
  • (2R)-2-(5-methoxy-2-nitrophenyl)oxirane
  • (I(3)R)-I(3)-Amino-4-(dodecyloxy)benzenepropanol
  • tert-butyl N-{3-hydroxy-4-[1-(hydroxymethyl)cyclopropyl]phenyl}carbamate
  • 3-(4-Amino-2-methylbutan-2-yl)phenol
  • 3-bromo-2-[4-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)but-2-ynamido]benzoic acid
  • 4-(3-Bromo-5-methoxypyridin-4-yl)-1,3-thiazol-2-amine
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.